5.61
price down icon2.26%   -0.13
pre-market  Pre-market:  5.50   -0.11   -1.96%
loading

Vivos Therapeutics Inc Stock (VVOS) Forecast

The Vivos Therapeutics Inc (VVOS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.7525, representing a -86.59% decrease from the current price of $5.61. The highest analyst price target is $1.3832, and the lowest is $0.1218.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VVOS Price Target
Average 1.2241 (-78.18% Downside)
loading

Is Vivos Therapeutics Inc (VVOS) A Buy Now?

Oscillators
Name Value Action
RSI(14) 65.75 Neutral
STOCH(9,6) 78.66 Neutral
STOCHRSI(14) 67.12 Neutral
MACD(12,26) 0.3826 Buy
ADX(14) 29.85 Buy
William %R -29.94 Neutral
CCI(14) 109.91 Buy
Buy: 3 Sell: 0 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
5.0374
Buy
5.2062
Buy
MA20
4.8352
Buy
4.8937
Buy
MA50
4.1139
Buy
4.2712
Buy
MA100
3.4255
Buy
3.745
Buy
MA200
2.9199
Buy
3.7422
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, VVOS could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 0 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on VVOS, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 65.75 indicates that VVOS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 78.66 indicates that VVOS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.12 indicates that VVOS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 29.85 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 109.91 indicates that VVOS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term VVOS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Vivos Therapeutics Inc financial reports and earnings history, Vivos Therapeutics Inc (VVOS) stock could reach $5.6446 by 2030, $16.10 by 2040 and $18.92 by 2050. See the projected annual prices until 2050 of the Vivos Therapeutics Inc stock below:

  • Vivos Therapeutics Inc (VVOS) is expected to reach an average price of $6.9246 in 2035, with a high prediction of $7.0231 and a low estimate of $6.9348. This indicates an $23.43% rise from the last recorded price of $5.61.
  • Vivos Therapeutics Inc (VVOS) stock is projected to chart a bullish course in 2040, with an average price target of $17.15, representing an $205.65% surge from its current level. The forecast ranges from a conservative $16.19 to a sky-high $16.10.
  • Our analysts predict Vivos Therapeutics Inc (VVOS) to jump 277.61% by 2045, soaring from $21.04 to an average price of $21.18, potentially reaching $20.90. While $21.04 is the low estimate, the potential upside is significant.
  • Vivos Therapeutics Inc (VVOS) stock is expected to climb by 2050, reaching an average of $18.54, a $230.42% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.92 and $18.62, respectively, highlighting the market's uncertainty.

Vivos Therapeutics Inc Stock (VVOS) Year by Year Forecast

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2025

Vivos Therapeutics Inc Stock (VVOS) is expected to reach an average price of $1.3522 in 2025, with a high prediction of $2.5825 and a low estimate of $0.1218. This indicates an -75.90% fall from the last recorded price of $5.61.
Month Average Low High Change from today's price
February, 2025 $0.2518 $0.1218 $1.3832 -95.51%
March, 2025 $0.6188 $0.3008 $0.4192 -88.97%
April, 2025 $0.3522 $0.6122 $0.5669 -93.72%
May, 2025 $1.9229 $1.5444 $1.5302 -65.72%
June, 2025 $1.8936 $1.6981 $1.4036 -66.25%
July, 2025 $1.5869 $1.6669 $1.9489 -71.71%
August, 2025 $0.7176 $1.3876 $1.4242 -87.21%
September, 2025 $1.1683 $0.7737 $0.9583 -79.18%
October, 2025 $1.8716 $1.4536 $1.7592 -66.64%
November, 2025 $2.3723 $2.1396 $1.897 -57.71%
December, 2025 $2.1657 $1.8703 $2.145 -61.40%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2026

The predicted value for Vivos Therapeutics Inc (VVOS) in 2026 is set at an average of $2.2188. Estimates vary from a peak of $2.7384 to a trough of $1.6991, indicating an -60.45% surge from the present price of $5.61.
Month Average Low High Change from today's price
January, 2026 $2.3863 $2.351 $2.3263 -57.46%
February, 2026 $2.387 $2.1617 $2.117 -57.45%
March, 2026 $2.1977 $2.3324 $2.1577 -60.83%
April, 2026 $2.5533 $2.2404 $2.2312 -54.49%
May, 2026 $2.5317 $2.6516 $2.5675 -54.87%
June, 2026 $2.6424 $2.5571 $2.5215 -52.90%
July, 2026 $2.7987 $2.6442 $2.6735 -50.11%
August, 2026 $1.5565 $2.6365 $2.7384 -72.26%
September, 2026 $1.8198 $1.6991 $1.6998 -67.56%
October, 2026 $2.3205 $2.0735 $2.2315 -58.64%
November, 2026 $2.5171 $2.5372 $2.4912 -55.13%
December, 2026 $2.4305 $2.4545 $2.4696 -56.68%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Vivos Therapeutics Inc (VVOS) is $23.57, with a high forecast of $46.62 and a low forecast of $0.52. This indicates an +320.16% increase from the last price of $5.61.
Month Average Low High Change from today's price
January, 2027 $2.3052 $2.3852 $2.3898 -58.91%
February, 2027 $2.1359 $2.2159 $2.2779 -61.93%
March, 2027 $2.2592 $2.0963 $2.1692 -59.73%
April, 2027 $2.1304 $2.2172 $2.2147 -62.02%
May, 2027 $2.1546 $2.1606 $2.1569 -61.59%
June, 2027 $2.0459 $2.1438 $2.1185 -63.53%
July, 2027 $0.9554 $0.8139 $2.748 -82.97%
August, 2027 $2.3047 $0.52 $2.8047 -58.92%
September, 2027 $9.2313 $1.902 $46.62 +64.55%
October, 2027 $4.4707 $4.4707 $10.75 -20.31%
November, 2027 $3.33 $2.9401 $7.1444 -40.64%
December, 2027 $2.9566 $2.8246 $4.322 -47.30%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2028

In 2028, Vivos Therapeutics Inc (VVOS) is projected to reach an average price of $3.3211, with a high projection of $6.0289 and a low estimate of $0.6133. This indicates an -40.80% fall from the last price of $5.61.
Month Average Low High Change from today's price
January, 2028 $1.2059 $1.1359 $3.4013 -78.50%
February, 2028 $0.7953 $0.6133 $1.6533 -85.82%
March, 2028 $3.998 $0.7326 $3.778 -28.73%
April, 2028 $3.0394 $3.5093 $2.974 -45.82%
May, 2028 $2.4761 $2.7354 $2.4171 -55.86%
June, 2028 $2.4275 $2.8975 $2.5337 -56.73%
July, 2028 $2.6888 $1.5728 $1.6388 -52.07%
August, 2028 $4.3155 $3.6695 $3.9855 -23.07%
September, 2028 $4.3769 $4.3509 $4.2769 -21.98%
October, 2028 $5.2182 $4.8022 $5.0382 -6.98%
November, 2028 $3.735 $4.2881 $6.0289 -33.42%
December, 2028 $4.1863 $3.9356 $3.6456 -25.38%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2029

The 2029 price forecast for Vivos Therapeutics Inc Stock (VVOS) is $5.3897 on average, with a high prediction of $6.0578 and a low estimate of $4.7217. This represents an -3.93% decrease from the previous price of $5.61.
Month Average Low High Change from today's price
January, 2029 $5.083 $4.7217 $4.8618 -9.39%
February, 2029 $4.6344 $4.8944 $4.8837 -17.39%
March, 2029 $6.1357 $5.8092 $5.7604 +9.37%
April, 2029 $6.0371 $5.8763 $5.5471 +7.61%
May, 2029 $5.6438 $5.7238 $6.0578 +0.60%
June, 2029 $4.7052 $5.3752 $5.4465 -16.13%
July, 2029 $5.0865 $4.7267 $4.8765 -9.33%
August, 2029 $5.7032 $5.3372 $5.5908 +1.66%
September, 2029 $6.1346 $5.9193 $5.6939 +9.35%
October, 2029 $5.8413 $5.5806 $5.8899 +4.12%
November, 2029 $5.9927 $5.992 $5.9327 +6.82%
December, 2029 $5.924 $5.7334 $5.698 +5.60%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2030

Vivos Therapeutics Inc Stock (VVOS) is expected to reach an average price of $5.3337 in 2030, with a high forecast of $5.9139 and a low forecast of $4.7536. This signifies an -4.92% decrease from the last price of $5.61.
Month Average Low High Change from today's price
January, 2030 $5.6707 $5.6907 $5.6446 +1.08%
February, 2030 $5.9343 $5.6914 $5.6122 +5.78%
March, 2030 $5.8435 $5.9634 $5.9139 +4.16%
April, 2030 $5.8848 $5.8342 $5.7842 +4.90%
May, 2030 $5.9544 $5.8554 $5.8462 +6.14%
June, 2030 $4.6429 $5.7229 $5.8769 -17.24%
July, 2030 $4.8196 $4.7536 $4.6996 -14.09%
August, 2030 $5.251 $5.0559 $5.162 -6.40%
September, 2030 $5.3782 $5.3983 $5.3584 -4.13%
October, 2030 $5.205 $5.229 $5.2961 -7.22%
November, 2030 $5.0104 $5.0904 $5.1344 -10.69%
December, 2030 $4.7718 $4.8518 $4.9657 -14.94%
medical_devices STE
$217.07
price up icon 3.55%
medical_devices ZBH
$110.52
price up icon 0.88%
medical_devices PHG
$26.57
price up icon 2.98%
$86.32
price up icon 2.30%
$87.34
price up icon 3.07%
medical_devices EW
$69.97
price up icon 0.27%
Cap:     |  Volume (24h):